| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant function of pathogenic STAT3 mutant proteins is linked to altered stability of monomers and homodimers
|
Kasembeli, Moses M.
|
|
|
141 |
12 |
p. 1411-1424
|
artikel
|
| 2 |
A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD
|
Kizlik-Masson, Claire
|
|
|
141 |
12 |
p. 1457-1468
|
artikel
|
| 3 |
A phase 2 study of interleukin-22 and systemic corticosteroids as initial treatment for acute GVHD of the lower GI tract
|
Ponce, Doris M.
|
|
|
141 |
12 |
p. 1389-1401
|
artikel
|
| 4 |
Back Matter
|
|
|
|
141 |
12 |
p. I
|
artikel
|
| 5 |
Context is key for FLT3-ITD
|
Meyer, Sara E.
|
|
|
141 |
12 |
p. 1373-1374
|
artikel
|
| 6 |
Editorial Board
|
|
|
|
141 |
12 |
p. x
|
artikel
|
| 7 |
FLT3ITD drives context-specific changes in cell identity and variable interferon dependence during AML initiation
|
Li, Yanan
|
|
|
141 |
12 |
p. 1442-1456
|
artikel
|
| 8 |
How I prevent and treat central nervous system disease in adults with acute lymphoblastic leukemia
|
Kopmar, Noam E.
|
|
|
141 |
12 |
p. 1379-1388
|
artikel
|
| 9 |
HU for SCA in Africa: associated malaria benefit
|
Odame, Isaac
|
|
|
141 |
12 |
p. 1370-1371
|
artikel
|
| 10 |
Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa
|
Olupot-Olupot, Peter
|
|
|
141 |
12 |
p. 1402-1410
|
artikel
|
| 11 |
IL-22, a new beacon in gastrointestinal aGVHD
|
Mohty, Mohamad
|
|
|
141 |
12 |
p. 1369-1370
|
artikel
|
| 12 |
Johnston RL, Mottok A, Chan FC, et al. A gene expression–based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma. Blood. 2022;139(6):889-893.
|
|
|
|
141 |
12 |
p. 1495
|
artikel
|
| 13 |
Keeping it together
|
Yee, Andrew
|
|
|
141 |
12 |
p. 1374-1376
|
artikel
|
| 14 |
Königs C, Ozelo MC, Dunn A, et al. First study of extended half-life rFVIIIFc in previously untreated patients with hemophilia A: PUPs A-LONG final results. Blood. 2022;139(26):3699-3707.
|
|
|
|
141 |
12 |
p. 1495
|
artikel
|
| 15 |
Lee JB, Khan DH, Hurren R, et al. Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production. Blood. 2021;138(3):234-245.
|
|
|
|
141 |
12 |
p. 1495
|
artikel
|
| 16 |
Masthead Subscription
|
|
|
|
141 |
12 |
p. v
|
artikel
|
| 17 |
Primary thymic marginal zone lymphoma with amyloidosis
|
Rozenova, Krasimira A.
|
|
|
141 |
12 |
p. 1494
|
artikel
|
| 18 |
Removal of the vicinal disulfide enhances the platelet-capturing function of von Willebrand factor
|
Tischer, Alexander
|
|
|
141 |
12 |
p. 1469-1473
|
artikel
|
| 19 |
Safety and efficacy of CPX-351 in younger patients (<60 years old) with secondary acute myeloid leukemia
|
Przespolewski, Amanda
|
|
|
141 |
12 |
p. 1489-1493
|
artikel
|
| 20 |
Table of Contents
|
|
|
|
141 |
12 |
p. vii-ix
|
artikel
|
| 21 |
Targeting a deubiquitinase blocks GVHD
|
Schroeder, Mark A.
|
|
|
141 |
12 |
p. 1376-1377
|
artikel
|
| 22 |
TCL1A expression promotes aggressive biology in CLL
|
Sahasrabuddhe, Anagh A.
|
|
|
141 |
12 |
p. 1371-1373
|
artikel
|
| 23 |
The OTUD1-Notch2-ICD axis orchestrates allogeneic T cell–mediated graft-versus-host disease
|
Cheng, Qiao
|
|
|
141 |
12 |
p. 1474-1488
|
artikel
|
| 24 |
The proto-oncogene TCL1A deregulates cell cycle and genomic stability in CLL
|
Stachelscheid, Johanna
|
|
|
141 |
12 |
p. 1425-1441
|
artikel
|
Tijdschrift beschrijving